Related Experiment Video

Updated: May 9, 2026

Models of Bone Metastasis
08:49

Models of Bone Metastasis

Published on: September 4, 2012

Myeloid TGF-β responsiveness promotes metastases

Fernando Souza-Fonseca-Guimaraes1, Mark J Smyth

  • 1Immunology in Cancer and Infection Laboratory, Queensland Institute of Medical Research, University of Queensland, Herston, Queensland, Australia.

Cancer Discovery
|August 10, 2013
PubMed

Insights

Tumor-induced immune suppression hinders cancer therapies. New research reveals myeloid-specific TGF-β signaling drives tumor metastasis, offering a target to improve treatments and reduce side effects.

Area of Science:

  • Immunology
  • Oncology
  • Cell Biology

Background:

  • Tumor-induced immune suppression impedes effective cancer therapies.
  • Transforming growth factor-beta (TGF-β) exhibits dual roles in tumor promotion and suppression.
  • Understanding TGF-β's specific functions is crucial for developing targeted cancer treatments.

Purpose of the Study:

  • To investigate the role of myeloid-specific TGF-β signaling in tumor metastasis.
  • To identify novel therapeutic targets for reducing cancer immunosuppression and metastasis.

Main Methods:

  • The study by Pang and colleagues utilized advanced techniques to analyze myeloid-specific TGF-β signaling pathways.
  • Experimental models were employed to assess the impact of TGF-β on tumor metastasis and immune suppression.

Main Results:

  • Myeloid-specific TGF-β signaling was identified as a critical mediator of tumor metastasis.
  • These findings highlight a specific mechanism through which tumors suppress the immune response.

Conclusions:

  • Targeting myeloid-specific TGF-β signaling presents a promising strategy to combat cancer metastasis.
  • This approach may enhance the efficacy of cancer therapies and minimize adverse events.

More Related Videos

Experimental Metastasis Assay08:28

Experimental Metastasis Assay

Published on: August 24, 2010

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...